logo-loader
viewProactive Group

Investor Update: Endorsement for Angle's liquid biopsy system Parsortix

Top stories from the Proactive Investors UK newsroom.

Angle (LON:AGL) has received an endorsement for its liquid biopsy system Parsortix from European cancer centre UKE, which says it has potential as a biomarker to test for lung cancer.

Security group Westminster (LON:WSG) has signed a collaboration agreement with Hazar International that will see the two work together on projects in Saudi Arabia.

Bushveld Minerals (LON:BMN) has published a maiden mineral resource estimate for the Brits vanadium Project in South Africa.

FairFX Group (LON:FFX) has received approval from the FCA to offer loan products to business and retail customers.

Shares in San Francisco-based workplace messaging service Slack soared in first dealings on the New York Stock Exchange last night.  The price jumped 60% to US$41 per share.

UK transport booking app Trainline is aiming for a £1.7bn valuation in its upcoming London flotation. The company priced its initial public offering at 350p per share – the top end of its targeted range.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Archer Materials looking to raise 3 million offering a Share Purchase Plan

Archer Materials ( ASX: AXE) CEO Dr Mohammad Choucair joined Proactive’s Steve Darling with news the company is looking to raise capital in a Share Purchase Plan which began June 1st. That plan will allow eligible shareholders the opportunity to purchase new Archer shares at a price of $0.60 per...

1 day, 15 hours ago

2 min read